Paper25670366
Changes in LDL particle concentrations after treatment with the cholesteryl ester transfer protein inhibitor anacetrapib alone or in combination with atorvastatin.
Krauss RM and 4 others. J Clin Lipidol, 2015. Cited by 17 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Changes in LDL particle concentrations after treatment with the cholesteryl ester transfer protein inhibitor anacetrapib alone or in combination with atorvastatin. Papers, record 25670366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25670366
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Changes in LDL particle concentrations after treatment with the cholesteryl ester transfer protein inhibitor anacetrapib alone or in combination with atorvastatin.
- PubMed
- Publication types
- Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticholesteremic Agents | Major topic |
| Dyslipidemias | Major topic |
| Heptanoic Acids | Major topic |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | Major topic |
| Oxazolidinones | Major topic |
| Pyrroles | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Apoproteins | |
| Atorvastatin | |
| Cholesterol Ester Transfer Proteins | |
| Cholesterol, LDL | |
| Double-Blind Method | |
| Drug Administration Schedule | |
| Female | |
| Humans | |
| Lipoproteins, HDL | |
| Lipoproteins, LDL | |
| Lipoproteins, VLDL | |
| Male | |
| Middle Aged | |
| Placebo Effect | |
| Treatment Outcome | |
| Triglycerides | |
| Young Adult |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30 DK026743 | NIDDK NIH HHS | United States | P30DK026743 | PubMed and NIH |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00325455 | MK0859 Dose-Ranging Study (0859-003) | Derived from the trial | Yes |
Source ClinicalTrials.gov
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19185645 | Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients. | Am Heart J | 2009 | https://conductscience.org/library/papers/19185645 | PubMed |
| 2 | 22130116 | Anacetrapib, a novel CETP inhibitor: pursuing a new approach to cardiovascular risk reduction. | Clin Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22130116 | PubMed |
| 3 | 22180633 | Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib. | J Lipid Res | 2012 | https://conductscience.org/library/papers/22180633 | PubMed |
| 4 | 12235168 | Metabolic origins and clinical significance of LDL heterogeneity. | J Lipid Res | 2002 | https://conductscience.org/library/papers/12235168 | PubMed |
| 5 | 15198488 | Use of the false discovery rate for evaluating clinical safety data. | Stat Methods Med Res | 2004 | https://conductscience.org/library/papers/15198488 | PubMed |
| 6 | 6403642 | Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. | J Lipid Res | 1983 | https://conductscience.org/library/papers/6403642 | PubMed |
| 7 | 8409761 | Plasma cholesteryl ester transfer protein. | J Lipid Res | 1993 | https://conductscience.org/library/papers/8409761 | PubMed |
| 8 | 8305409 | A new in vitro method for the simultaneous evaluation of cholesteryl ester exchange and mass transfer between HDL and apoB-containing lipoprotein subspecies. Identification of preferential cholesteryl ester acceptors in human plasma. | Arterioscler Thromb | 1994 | https://conductscience.org/library/papers/8305409 | PubMed |
| 9 | 8640407 | Differences in receptor binding of LDL subfractions. | Arterioscler Thromb Vasc Biol | 1996 | https://conductscience.org/library/papers/8640407 | PubMed |
| 10 | 16574893 | Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans. | Arterioscler Thromb Vasc Biol | 2006 | https://conductscience.org/library/papers/16574893 | PubMed |
| 11 | 18515257 | Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis. | Clin Chem | 2008 | https://conductscience.org/library/papers/18515257 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41549108 | Comparative efficacy of obicetrapib and anacetrapib in reducing low-density lipoprotein (LDL) levels: a network meta-analysis of clinical trials. | Daru | 2026 | https://conductscience.org/library/papers/41549108 | PubMed |
| 37047642 | Exploring the Association between Low-Density Lipoprotein Subfractions and Major Adverse Cardiovascular Outcomes-A Comprehensive Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047642 | PubMed |
| 34829807 | Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options. | Biomedicines | 2021 | https://conductscience.org/library/papers/34829807 | PubMed |
| 31475865 | Association of lowering apolipoprotein B with cardiovascular outcomes across various lipid-lowering therapies: Systematic review and meta-analysis of trials. | Eur J Prev Cardiol | 2020 | https://conductscience.org/library/papers/31475865 | PubMed |
| 28961179 | Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias? | Diseases | 2017 | https://conductscience.org/library/papers/28961179 | PubMed |
| 28314859 | Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E. | J Lipid Res | 2017 | https://conductscience.org/library/papers/28314859 | PubMed |
| 26408274 | Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or Placebo: The Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial. | Circulation | 2015 | https://conductscience.org/library/papers/26408274 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| APOA1 | 335 | PubTator's text mining | https://conductscience.org/library/genes/335 | NCBI Gene |
| APOB | 338 | PubTator's text mining | https://conductscience.org/library/genes/338 | NCBI Gene |
| APOC3 | 345 | PubTator's text mining | https://conductscience.org/library/genes/345 | NCBI Gene |
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| CETP | 1071 | PubTator's text mining | https://conductscience.org/library/genes/1071 | NCBI Gene |
| LDLR | 3949 | PubTator's text mining | https://conductscience.org/library/genes/3949 | NCBI Gene |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| ANACETRAPIB | CHEMBL1800807 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1800807 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25670366
GET https://conductscience.org/api/papers/v1/25670366/authors